OBJECTIVE: To assess the prevalence of patient-reported, physician-diagnosed comorbid conditions in women with endometriosis. DESIGN: Cross-sectional study of self-reported survey data. SETTING: Academic research. PATIENT(S): Four thousand three hundred thirty-one Endometriosis Association (EA) members reporting surgically diagnosed endometriosis. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Self-reported, physician-diagnosed infectious diseases, cancers, and endocrine diseases. RESULT(S): Nearly two-thirds of women reported one or more of the assessed conditions. Recurrent upper respiratory infections and recurrent vaginal infections were common and more likely in women responding to the EA survey. Melanoma was reported by 0.7% (n=29), breast cancer by 0.4% (n=16), and ovarian cancer by 0.2% (n=10). While ovarian cancer and melanoma were significantly more common than in the general population, breast cancer was surprisingly less common. Addison's disease and Cushing's syndrome were rare (0.2% and 0.1%, respectively). CONCLUSION(S): Respondents reported a higher prevalence of recurrent upper respiratory or vaginal infections, melanoma, and ovarian cancer than the general population. These findings document other potential associations related to the immune system, which may help focus future research into this disease. Published by Elsevier Inc.
OBJECTIVE: To assess the prevalence of patient-reported, physician-diagnosed comorbid conditions in women with endometriosis. DESIGN: Cross-sectional study of self-reported survey data. SETTING: Academic research. PATIENT(S): Four thousand three hundred thirty-one Endometriosis Association (EA) members reporting surgically diagnosed endometriosis. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Self-reported, physician-diagnosed infectious diseases, cancers, and endocrine diseases. RESULT(S): Nearly two-thirds of women reported one or more of the assessed conditions. Recurrent upper respiratory infections and recurrent vaginal infections were common and more likely in women responding to the EA survey. Melanoma was reported by 0.7% (n=29), breast cancer by 0.4% (n=16), and ovarian cancer by 0.2% (n=10). While ovarian cancer and melanoma were significantly more common than in the general population, breast cancer was surprisingly less common. Addison's disease and Cushing's syndrome were rare (0.2% and 0.1%, respectively). CONCLUSION(S): Respondents reported a higher prevalence of recurrent upper respiratory or vaginal infections, melanoma, and ovarian cancer than the general population. These findings document other potential associations related to the immune system, which may help focus future research into this disease. Published by Elsevier Inc.
Authors: Kaylon L Bruner-Tran; Grant R Yeaman; Marta A Crispens; Toshio M Igarashi; Kevin G Osteen Journal: Fertil Steril Date: 2008-04-18 Impact factor: 7.329
Authors: K Obata; S J Morland; R H Watson; A Hitchcock; G Chenevix-Trench; E J Thomas; I G Campbell Journal: Cancer Res Date: 1998-05-15 Impact factor: 12.701
Authors: Louise A Brinton; Carolyn L Westhoff; Bert Scoccia; Emmet J Lamb; Michelle D Althuis; Jerome E Mabie; Kamran S Moghissi Journal: Epidemiology Date: 2005-07 Impact factor: 4.822
Authors: Andrew Berchuck; Joellen M Schildkraut; Robert M Wenham; Brian Calingaert; Shazia Ali; Amy Henriott; Susan Halabi; Gustavo C Rodriguez; Dorota Gertig; David M Purdie; Livia Kelemen; Amanda B Spurdle; Jeffrey Marks; Georgia Chenevix-Trench Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-12 Impact factor: 4.254
Authors: H Baranova; R Bothorishvilli; M Canis; E Albuisson; S Perriot; E Glowaczower; M A Bruhat; V Baranov; P Malet Journal: Mol Hum Reprod Date: 1997-09 Impact factor: 4.025
Authors: Leslie V Farland; Rulla M Tamimi; A Heather Eliassen; Donna Spiegelman; Susan E Hankinson; Wendy Y Chen; Stacey A Missmer Journal: Obstet Gynecol Date: 2016-11 Impact factor: 7.661
Authors: Leslie V Farland; Rulla M Tamimi; A Heather Eliassen; Donna Spiegelman; Laura C Collins; Stuart J Schnitt; Stacey A Missmer Journal: Breast Cancer Res Treat Date: 2016-09-07 Impact factor: 4.872
Authors: Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer Journal: Hum Reprod Update Date: 2015-03-11 Impact factor: 15.610
Authors: Leslie V Farland; Rulla M Tamimi; A Heather Eliassen; Donna Spiegelman; Kimberly A Bertrand; Stacey A Missmer Journal: Cancer Causes Control Date: 2016-08-22 Impact factor: 2.506